Brown Advisory Inc. Has $40.12 Million Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Brown Advisory Inc. increased its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 6.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,628,747 shares of the company's stock after purchasing an additional 94,719 shares during the quarter. Brown Advisory Inc. owned approximately 6.71% of OrthoPediatrics worth $40,116,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in KIDS. Bank of New York Mellon Corp grew its holdings in shares of OrthoPediatrics by 3.8% during the 4th quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company's stock worth $1,338,000 after purchasing an additional 2,099 shares during the period. Charles Schwab Investment Management Inc. increased its position in OrthoPediatrics by 2.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company's stock worth $3,158,000 after buying an additional 3,800 shares during the period. HighTower Advisors LLC bought a new position in shares of OrthoPediatrics in the fourth quarter worth $268,000. American Century Companies Inc. grew its stake in shares of OrthoPediatrics by 13.2% in the fourth quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock worth $612,000 after purchasing an additional 3,072 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in OrthoPediatrics during the fourth quarter worth about $79,000. Hedge funds and other institutional investors own 69.05% of the company's stock.

OrthoPediatrics Trading Down 2.5%

KIDS traded down $0.56 during midday trading on Friday, reaching $21.89. 89,014 shares of the company were exchanged, compared to its average volume of 198,803. The company has a debt-to-equity ratio of 0.21, a quick ratio of 2.99 and a current ratio of 6.19. OrthoPediatrics Corp. has a one year low of $19.52 and a one year high of $35.99. The stock has a market capitalization of $531.71 million, a P/E ratio of -12.51 and a beta of 1.10. The stock's 50-day simple moving average is $21.54 and its 200 day simple moving average is $23.05.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). OrthoPediatrics had a negative return on equity of 7.03% and a negative net margin of 19.15%. The company had revenue of $52.41 million for the quarter, compared to the consensus estimate of $51.68 million. As a group, analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on KIDS. Piper Sandler dropped their price target on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a research note on Thursday, May 8th. Truist Financial decreased their target price on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Lake Street Capital assumed coverage on OrthoPediatrics in a research report on Monday, April 7th. They issued a "buy" rating and a $37.00 price objective for the company. Wall Street Zen raised OrthoPediatrics from a "sell" rating to a "hold" rating in a research report on Friday, June 27th. Finally, Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a research note on Thursday, May 8th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $35.83.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.